Likelihood of reporting adverse events in community pharmacy: an experimental study

被引:39
|
作者
Ashcroft, DM
Morecroft, C
Parker, D
Noyce, PR
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Ctr Innovat Practice, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England
来源
QUALITY & SAFETY IN HEALTH CARE | 2006年 / 15卷 / 01期
关键词
D O I
10.1136/qshc.2005.014639
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In the UK the National Reporting and Learning System (NRLS) is designed to coordinate the reporting of patient safety incidents nationally and to improve the ability of the health service to learn from the analysis of these events. Little is known about levels of engagement with the NRLS. Objective: To examine the likelihood of community pharmacists and support staff reporting patient safety incidents which occur in community pharmacies. Methods: Questionnaire survey containing nine incident scenarios. In the scenarios two factors were orthogonally manipulated: the outcome for the patient was reported as good, bad or poor, and the behaviour of the pharmacist was described as either complying with a protocol, not being aware of a protocol (error), or violating a protocol. Respondents were asked to rate whether they would report the incident (1) locally within the pharmacy and (2) nationally to the National Patient Safety Agency (NPSA). Results: 275 questionnaires were returned (79% response rate) from 223 community pharmacists and 52 members of support staff. There were significant main effects for both patient outcome (F(2,520) = 18.19, p < 0.001) and behaviour type (F(2,520) = 93.98, p, 0.001), indicating that pharmacists and support staff would take into account both the outcome of the behaviour and whether or not it follows a protocol when considering to report an incident within the pharmacy. Likewise, both pharmacists and support staff considered patient outcome (F(2,524) = 12.59, p, 0.001) and behaviour type (F(2,524) = 34.82, p, 0.001) when considering to report to the NPSA. Both locally and nationally, the likelihood of reporting any incident was low, and judgements on whether to report were more affected by the behaviour of the pharmacist in relation to protocols than the resulting outcome for the patient. Conclusions: Community pharmacists and their support staff would be unlikely to report adverse incidents if they witnessed them occurring in a community pharmacy. They remain to be convinced that the advantages to them and their patients outweigh the consequences of blame.
引用
下载
收藏
页码:48 / 51
页数:4
相关论文
共 50 条
  • [21] Attitudes and knowledge of community pharmacy professionals regarding the spontaneous reporting of adverse drug reactions: a preliminary study in Coimbra, Portugal
    Matos C.
    Joaquim J.
    Pires T.
    Drugs & Therapy Perspectives, 2017, 33 (2) : 88 - 94
  • [22] Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh
    Amin, Mohammad Nurul
    Khan, Tahir Mehmood
    Dewan, Syed Masudur Rahman
    Islam, Mohammad Safiqul
    Moghal, Mizanur Rahman
    Ming, Long Chiau
    BMJ OPEN, 2016, 6 (08):
  • [23] Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events
    Bukirwa, Hasifa
    Nayiga, Susan
    Lubanga, Rosalind
    Mwebaza, Norah
    Chandler, Clare
    Hopkins, Heidi
    Talisuna, Ambrose O.
    Staedke, Sarah G.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2008, 13 (09) : 1143 - 1152
  • [24] Adverse Events of Desvenlafaxine Using FDA Adverse Events Reporting System
    Karydes, H. C.
    Leikin, J. B.
    CLINICAL TOXICOLOGY, 2010, 48 (06) : 664 - 664
  • [25] Study of the adverse reactions of hormonal contraceptives from the community pharmacy
    Garcia Sevillano, Luis
    Arranz Madrigal, Esther
    PHARMACEUTICAL CARE ESPANA, 2014, 16 (03): : 98 - 109
  • [26] Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen
    Mohammed, Yaser
    Al-Worafi
    Kassab, Yaman Walid
    Alseragi, Wafa Mohammed
    Almutairi, Masaad Saeed
    Ahmed, Ali
    Ming, Long Chiau
    Alkhoshaiban, Ali Saleh
    Hadi, Muhammad Abdul
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1175 - 1181
  • [27] Balancing the outcomes: reporting adverse events
    Keech, AC
    Wonders, SM
    Cook, DI
    Gebski, VJ
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (04) : 215 - 218
  • [28] Reporting adverse events and lack of efficacy
    Davies, Heather
    Noble, P-J M.
    Pinchbeck, Gina
    Killick, David R.
    Diesel, Gillian
    VETERINARY RECORD, 2020, 187 (10) : 407 - 407
  • [29] Terminology for reporting adverse events updated
    Baldwin, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1103 - 1104
  • [30] Reporting and Notification of Adverse Events in Orthopaedics
    Mihalko, William M.
    Greenwald, A. Seth
    Lemons, Jack
    Kirkpatrick, John
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2010, 18 (04) : 193 - 198